From vaccine hostility to the dismantling of USAID, the consequences of this year’s retrenchments will be felt for years to come.
Alice Park
Park is a senior health correspondent at TIME. She covers the COVID-19 pandemic, new drug developments in cancer and Alzheimer’s disease, mental health, HIV, CRISPR, and advances in gene therapy, among other issues in health and science. She also covers the Olympics and co-chaired TIME’s inaugural TIME 100 Health Summit in 2019. Her work has won awards from the New York Press Club and recognition from the Deadline Club. In addition, she is the author of The Stem Cell Hope: How Stem Cell Medicine Can Change Our Lives. Follow her on Instagram at @aliceparktime.
Researchers make the case for a personalized approach to mammograms.
The change represents a continued shift in the agency’s vaccine policy, reflecting increasingly skeptical views.
The latest report from the Gates Foundation predicts an alarming trend for the health of children around the world.
Ralph Lauren’s new uniforms for Team USA highlight white, classic American design ahead of the 2026 Winter Olympics.
Advertisement
A new study reports some unexpected results.
Novo Nordisk reports disappointing results from the first large study of GLP-1 weight-loss drugs and their effect on Alzheimer’s disease.
The actor, who inherited a high-risk gene for Alzheimer’s disease, explores ways to potentially slow down the disease.
A new survey reveals growing divides on issues related to vaccines.
Experts applauded the decision, and anticipate that more perimenopausal and menopausal women will benefit from the health benefits of the treatment
Advertisement
Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.
Even relatively small amounts of activity can benefit the brain.
Research shows women’s hearts may benefit more from exercise—at half the effort men need.
Dr. Robert Montgomery talks about performing one of the first transplants of a genetically modified pig kidney into a living patient.
Meta: {"__typename":"TimeAuthorPageMetadata","title":"Alice Park | TIME","description":"Read the latest stories by Alice Park on Time","path":"https://time.com/author/alice-park","showScaleAiChat":true,"openGraph":{"__typename":"OpenGraphMeta","title":"Alice Park | TIME","description":"Read the latest stories by Alice Park on Time","url":"https://time.com/author/alice-park","type":"website","siteName":"TIME","images":[{"__typename":"OpenGraphImage","height":"300","url":"https://time.com/wp-content/themes/time2014/img/time-logo-og.png","width":"300"}]},"twitter":{"__typename":"TwitterMeta","title":"Alice Park | TIME","description":"Read the latest stories by Alice Park on Time","site":"@TIME","url":"https://time.com/author/alice-park","card":"summary_large_image","images":[{"__typename":"TwitterImage","url":"https://time.com/wp-content/themes/time2014/img/time-logo-og.png"}]},"pinterest":{"__typename":"PinterestMeta","url":"https://time.com/author/alice-park","description":"Read the latest stories by Alice Park on Time","media":"https://time.com/wp-content/themes/time2014/img/time-logo-og.png"},"fb":{"__typename":"FacebookMeta","app_id":"991230477954201","pages":"10606591490"}}